Our community narratives are driven by numbers and valuation.
Jamjoom Pharmaceuticals looks set to ride a wave of growing healthcare demand across the Middle East and North Africa, helped by new medicines, licensing deals, and upgrades that could make its factories run more efficiently. But the story hinges on whether it can grow without getting squeezed by lower-profit sales channels, price pressure, and the risks that come with relying on partners and a single region.Read more
